# Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

> **NCT04448496** · PHASE4 · UNKNOWN · sponsor: **Yeungnam University College of Medicine** · enrollment: 49 (estimated)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Dexamethasone implant

## Key facts

- **NCT ID:** NCT04448496
- **Lead sponsor:** Yeungnam University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-22
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448496, "Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04448496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*